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Abstract
Disparities in incidence and mortality rates of colon cancer exist between Whites and African
Americans. Prior studies examined the association between trans fatty acid consumption and
colorectal cancer, but none assessed this possible relationship within a large study population of
African Americans and Whites. Using data from a population-based case-control study in North
Carolina, we investigated this association with attention to possible racial differences. Cases and
matched controls were queried on demographic characteristics, lifestyle factors, medical history, and
diet. Cases reported higher daily consumption (grams/day) of trans fatty acids [mean 5.9 (SD 2.9)
and median 5.5 (IQR 3.8-7.5)] compared to controls [mean 5.2 (SD 2.4) and median 4.7 (IQR
3.5-6.4)]. Energy-adjusted trans fatty acid consumption was not associated with colon cancer.
Compared to participants in the lowest quartile of consumption, those in the highest quartile had an
adjusted odds ratio of 1.01 (95% confidence interval 0.69, 1.49) for Whites and 0.99 (95% confidence
interval 0.61, 1.62) for African Americans. No association was found between increased consumption
of trans fatty acid and specific tumor location (proximal or distal colon). In conclusion, trans fatty
acid consumption is not associated with colon cancer and does not contribute to disparities in colon
cancer rates.
Introduction
Colorectal cancer is one of the most common cancers in the United States. There are appreciable
disparities in incidence and mortality rates by race, with a higher burden of disease among
African Americans. In the United States, the age-adjusted incidence rate for colorectal cancer
is 70.2/100,000 for African American men compared to 63.7/100,000 for White men. The
disparity is also seen among women, with African American women having an age-adjusted
incidence rate of 53.5/100,000 compared to 45.9/100,000 in White women (1).
The etiology of colorectal cancer is thought to be due largely to environmental factors, such
as physical activity and diet. Migrant studies have shown that, with increasing duration of
residence, migrants have rates of colorectal cancer similar to those of their adopted country
(2,3). Diet is thought to be one of the strongest environmental risk factors for colorectal cancer
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(4,5). In a recent report from the World Cancer Research Fund/American Institute for Cancer
Research, a panel concluded that consumption of red and processed meats and alcohol are
likely to increase the risk of colorectal cancer (6).
Although socioeconomic factors and differential screening rates between African Americans
and Whites may partly explain the disparity in colorectal cancer incidence, diet may play a role
as well. Previous research using the North Carolina Colon Cancer Study I found that African
Americans and Whites have different consumption patterns for various groups of foods (7).
One of the components of diet that differed between these races was “fats, oils, and snacks,”
with African Americans having a higher mean daily intake than Whites. This category included
unsaturated, saturated, and trans fatty acids. Other reports from this study showed similar mean
daily intakes of total fat and saturated fatty acids for Whites and African Americans (8).
Total dietary fat has previously been postulated to affect the risk of developing colorectal cancer
but the majority of studies have shown no association (9,10). It is possible, however, that it is
not overall fatty acid consumption but perhaps specific fatty acid subgroups that may be
relevant to the etiology of colon cancer. For example, some studies have found consumption
of n-3 polyunsaturated fatty acids to be inversely associated with colorectal cancer (11,12),
although the results are inconsistent (11-14). Recently there has been concern over the health
effects of trans fatty acid consumption. Trans fatty acids have been linked to increased risk of
heart disease (15) and potentially type II diabetes (16). A few studies examined the association
between colorectal cancer and trans fatty acid consumption (11-13,17) and reported
inconsistent results. None of these studies has looked at this relationship within a large
population of African Americans and Whites. If trans fatty acid consumption does play an
etiological role in colon cancer, it is possible that differential consumption patterns between
Whites and African Americans may account for some of the disparity in colorectal cancer
incidence rates. In North Carolina, for instance, White men have an age-adjusted colorectal
cancer incidence rate of 52.3/100,000 compared with a rate of 64.6/100,000 among African
American men. For women in North Carolina, the incidence rates are 38.7 and 51.4/100,000
respectively (18).
The objectives of this study were to examine the associations of trans fatty acid consumption
and colon cancer both overall and by location, as certain factors may affect the risk of colon
cancer differently for the proximal and distal colon. This study contributes to the existing body
of knowledge by exploring possible differences in the association by race using a large
population-based sample.
Materials and Methods
The North Carolina Colon Cancer Study I (NCCCS I) was a large population-based case-
control study conducted in central North Carolina. It enrolled subjects from 33 counties,
representing urban, suburban, and rural areas of the state. The study was approved by the
Institutional Review Board at the University of North Carolina School of Medicine.
Study Population
Cases were identified using the rapid case ascertainment system of the North Carolina Central
Cancer Registry. Those patients with a first diagnosis of histologically confirmed
adenocarcinoma of the colon between October 1996 and September 2000 were classified as
potential cases. Additional eligibility requirements were as follows: aged 40-80 years,
residence in one of the 33 study counties, able to give informed consent, able to complete an
interview, had a North Carolina driver's license or identification card (if under the age of 65),
and had received no denial by their primary physician for us to contact them.
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Potential cases received a call from a race-matched enrollment specialist, who explained the
study and scheduled an in-person interview with the patient once consent had been obtained.
On average, interviews took place within five months of the participant's diagnosis. White
cases were under-sampled for recruitment in order to increase the proportion of non-White
cases in the study population.
Controls were selected from two sources: the North Carolina Department of Motor Vehicles
records (for participants under the age of 65) and the Center for Medicare and Medicaid
Services (previously the Health Care Financing Administration) records (for those 65 years
and older). Potential controls were contacted in a manner similar to that of the cases. Controls
were matched to cases using randomized recruitment strategies (19) with recruitment
probabilities defined according to strata of 5-year age, sex, and race groups.
Data Collection
Interviews were conducted by trained nurse interviewers at the participant's residence or
another convenient location. Participants were asked questions about demographic
information, lifestyle factors, medical history, and diet. Physical activity was measured for
occupational, non-occupational, and non-work/weekend activities using a modified version of
a seven-day physical activity recall (20-22). Frequency, intensity, and duration was estimated
and converted into a variable estimating MET minutes per day. Interviewers also measured the
height and weight of each participant. They recorded the participant's self-reported weight for
one year prior in order to capture weight prior to illness or cancer therapy for cases. Both cases
and controls were offered a $25 incentive for participation in the study.
Dietary Information
Dietary information was collected using a modified version of the 100-item semiquantitiative
Block Food Frequency Questionnaire (FFQ) (23). Twenty-nine foods commonly consumed in
North Carolina were added to the questionnaire to offer local cuisine choices to participants.
Each food item had three choices for portion size (given as “small,” “medium,” and “large”)
and nine choices for frequency (ranging from “never or less than once per month” to “2+ times
per day”). When estimating frequency and portion size, study participants were asked to use a
reference period of the year prior to diagnosis (for cases) or interview (for controls) so that
seasonal variations in diet could be captured. Additional questions were asked about the
following: types of foods/oils used in cooking and preparation techniques, fats used in cooking,
fortified beverage consumption, low-fat food consumption, and restaurant eating.
The version of the Block FFQ that we used did not contain nutritional information on trans
fatty acids for any of the foods it included. Therefore, with the assistance of the Clinical
Nutrition Research Center at the University of North Carolina, we paired each food listed in
the Block FFQ with foods listed in the National Cancer Institute's Diet and History
Questionnaire (DHQ). We assigned the amount of trans fatty acid listed for each food in the
DHQ to the corresponding food in the Block FFQ (per 100 grams of food). If more than one
DHQ food matched, we applied the mean amount of trans fatty acids for those foods to the
corresponding Block FFQ food. Of the 201 Block FFQ foods, 176 (87.6%) were matched to
foods in the DHQ. For the remaining foods, we searched for trans fatty acid values in the USDA
National Nutrient Database for Standard Reference (Release 19) and eight more foods were
assigned values (4.0% of all foods). We were unable to determine the amount of trans fatty
acid in 17 foods (8.5%), which were assigned values of 0 grams of trans fatty acid. We
employed the same methods to estimate energy (i.e. caloric) intake. One hundred percent of
the Block FFQ foods were matched and assigned caloric values. The original values for caloric
intake present in the Block FFQ and the values determined using the DHQ and USDA databases
were highly correlated (correlation was greater than 0.99).
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We excluded participants with extreme or implausible values for energy intake [men: total
kcal/day <800 or >5000 (n=10); women: total kcal/day <600 or >4000 (n=21)]. In addition,
participants whose self-reported race was “other” were removed from further analyses (n=11).
We energy-adjusted the trans fatty acid variable using the residual method with total energy
intake as the independent variable and trans fatty acid intake as the dependent variable (24,
25). This allowed us to investigate the association between trans fatty acid consumption and
colon cancer independent of the amount of total energy consumed. In addition, energy
adjustment removes potential variation contributed to the association by total energy intake
(24). This method is often used for continuous nutrient values but is also an acceptable method
of energy adjustment when the nutrient values are categorized (25). Residuals of trans fatty
acid consumption were then divided into quartiles based on the distribution of consumption in
the control population.
Unconditional logistic regression models were used to examine the relationship between
colorectal cancer and trans fatty acid consumption. In all models, we included an offset term
to account for the randomized recruitment sampling fractions (19). Highest educational level
achieved (dichotomized as high school or less, more than high school), sex, and non-steroidal
anti-inflammatory drug (NSAID) use (dichotomized as never/rare use, frequent use) were
assessed as potential effect measure modifiers using tests of homogeneity and likelihood ratio
tests with an a priori p-value cut-off of 0.15. Similar studies found that the relationship between
trans fatty acid consumption and colon/colorectal cancer varied by sex (12,17) and NSAID
use (17). Previous research has shown NSAID use to be inversely associated with colon cancer
(26). NSAIDs could affect the association between trans fatty acid consumption and colon
cancer if inflammation resulting from trans fatty acid consumption (27) affects the
development of colon cancer. Highest level of education achieved was used as a proxy for
socioeconomic status, as individuals with low socioeconomic status may have less access fresh
foods (resulting in higher consumption of trans fatty acids). None of these were found to be
odds ratio modifiers and interaction terms were not retained in the final models. Using the 10%
change in estimate criterion with backwards elimination, we assessed the following variables,
which have previously been found to be associated with colorectal cancer and which may be
associated with trans fatty acid consumption, as potential confounding variables: family history
of colorectal cancer (yes, no), body mass index (BMI) one year prior (normal, overweight,
obese according to the World Health Organization cut-points), physical activity (quartiles
based on the control group), NSAID use (never, occasional, regular), smoking status (never,
former, current), highest level of education achieved (high school degree or less, some college,
college degree or higher) alcohol consumption (none, one or fewer drinks/day, more than 1
drink/day), and total fatty acid consumption, dietary fiber consumption, folate consumption
(dietary and supplemental), calcium consumption (dietary and supplemental), red meat
consumption, total fruit/fruit juice consumption, and total vegetable consumption (quartiles
based on the control groups). All models also included a term for the matching factors (five-
year age and sex stratum) as well as total energy intake. We found that the only confounder of
the energy-adjusted model was calcium intake; therefore, it was included with total energy
intake, the matching factors, and the offset term in the final model.
We further explored the relationship between trans fatty acid consumption and colorectal
cancer by examining the location of the cancer. Cases were categorized as having proximal
tumors if the cancer was present in the cecum, ascending colon, hepatic flexure, or transverse
colon. Cancers were considered distal tumors if they were present in the splenic flexure,
descending colon, or sigmoid colon. Cases with unspecified tumor locations or overlapping
lesions were excluded from this analysis (n=59). We estimated these associations using
multinomial logistic regression and reevaluated potential odds ratio modifiers and confounders
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using the aforementioned criteria. Due to the limitations of multinomial logistic regression, we
were not able to include an offset term with these models. Alcohol consumption and calcium
intake were confounders of the energy-adjusted model based on our change-in-estimate
criterion and were included in the energy-adjusted model with the matching factors and energy
intake.
Results
Among those who were eligible, reasons for not being interviewed were as follows: refusal
(14% cases; 36% controls), untraceable (1% cases, 1% controls), not reachable by phone (6%
cases, 1% controls), and physician denial (7% cases). Completed interviews were obtained for
1691 participants (643 cases, 1048 controls). The rate of study cooperation (interviewed/
(interviewed+refused)) was 84% for cases and 63% for controls. Response rates (interview/
eligible) for cases and controls were 72% and 61%, respectively. Excluding the aforementioned
participants with implausible dietary values or self-reported “other” race, our final study
population included 623 cases (341 Whites and 282 African Americans) and 1020 controls
(606 Whites and 414 African Americans).
Characteristics of the study population are given in Table 1. The majority of participants were
over 60 years old with less than a college degree. The proportion in both cases and controls of
participants with a high school degree or less was greater among African Americans than
Whites (cases: 72.3% versus 57.1%; controls: 69.1% versus 48.8%). Overall, cases had a higher
mean BMI than controls [29.4 (standard deviation: 6.1) versus 28.4 (standard deviation: 5.8),
respectively]. The proportion of African American cases and controls classified as overweight
or obese (BMI of 25 kg/m2 or higher) one year prior to diagnosis/interview was greater than
the proportion of White cases and controls, respectively. Cases of both races were more likely
to have a family history of colorectal cancer. Both Whites and African American cases reported
higher total energy intake than their respective controls, and total energy intake was found to
be associated with colon cancer among both races. This was demonstrated using a t-test as well
as a logistic regression model adjusted for other potential confounders [p-values <0.01 for t-
tests among both Whites and African Americans; logistic regression results for 100 kcal units
of total energy intake: Whites, OR=1.05 (95% CI 1.02, 1.08); African Americans, OR=1.05
(95% CI 1.02, 1.07). Also trans fatty acid consumption and total energy intake were correlated
in the control group (Pearson correlation coefficients greater than 0.79 overall and among
Whites and African Americans).
Cases also had a higher mean daily intake of trans fatty acid than controls. White cases reported
a mean (standard deviation) and median (interquartile range) trans fatty acid consumption of
5.9 (2.7) and 5.5 (3.9, 7.3) grams per day compared with 5.2 (2.4) and 4.8 (3.5, 6.4) grams per
day for White controls (t-test p<0.01; Wilcoxon rank-sum test p<0.01). The mean (standard
deviation) and median for African Americans were 6.1 (3.2) and 5.4 (3.7, 7.5) grams per day
among cases and 5.2 (2.6) and 4.7 (3.5, 6.4) grams per day among controls, respectively (t-test
p<0.01, Wilcoxon rank-sum test p<0.01). Although African American cases had a higher mean
daily intake of trans fatty acids compared to White cases, these values were not statistically
different (p-value 0.34).
Prior to adjustment for total energy intake, colon cancer was positively associated with high
trans fatty acid consumption. Odds ratios adjusted for confounding factors other than energy
intake comparing the fourth quartile with the first quartile of trans fatty acid consumption were
2.01 (95% CI: 1.22, 3.30) for Whites and 2.50 (95% CI: 1.40, 4.47) for African Americans
(Table 2). This relationship did not persist in energy-adjusted analyses. The adjusted odds ratios
for the fourth quartiles of consumption compared with the lowest quartiles were 1.01 (95% CI:
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0.69, 1.49) and 0.99 (95% CI: 0.61, 1.62) for Whites and African Americans, respectively
(Table 2).
In addition, we investigated whether the relationship between trans fatty acid consumption and
cancer differed by tumor location (Table 3). There was no association present for proximal or
distal colon cancer in relation to trans fatty acid consumption. Among Whites, the adjusted
odds ratios (95% confidence intervals) for the highest quartile compared to the lowest quartile
of intake were 1.05 (95% CI: 0.60, 1.83) and 0.92 (95% CI: 0.55, 1.56) for the proximal and
distal colon, respectively. Adjusted odds ratios (95% confidence intervals) were 1.35 (95% CI:
0.71, 2.55) and 0.69 (95% CI: 0.36, 1.31), respectively, among African Americans.
Discussion
In this population-based case-control study of colon cancer in North Carolina, trans fatty acid
consumption was not associated with colon cancer in either Whites or African Americans. In
addition, the association did not differ between proximal or distal colon cancer locations. The
point estimate for the highest quartile of trans fatty acid was greater for the proximal colon
compared with the distal colon among African Americans, but due to a lack of precision we
were unable to establish whether high trans fatty acid consumption was truly associated with
cancer in this section of the colon. Without energy-adjustment there was a modest positive
association between trans fatty acid consumption and colon cancer but because this association
was not present in the energy-adjusted model, we conclude that it was likely due to
confounding.
The greater consumption of “fats, oils, and snacks” by African Americans in comparison to
the consumption by Whites previously illustrated in our research (7) does not appear to be due
to trans fatty acid consumption, as Whites and African Americans had similar daily intakes of
trans fatty acids in the present analyses. Moreover, the absence of an association between
trans fatty acid consumption and colon cancer in energy-adjusted analyses, combined with the
similarity in trans fatty acid consumption between the races, makes it unlikely that trans fatty
acid consumption contributes to the disparity in colon cancer rates observed between Whites
and African Americans.
To date, results of studies examining the association between colorectal cancer and trans fatty
acid consumption have been mixed. Three previous case-control studies investigated at the
association between trans fatty acid consumption and colon (17) and colorectal cancer (11,
12). One demonstrated that higher consumption was positively associated with colon cancer
for post-menopausal women not on hormone replacement therapy (17) and another found an
elevated relative risk among women, in general (12). There was no association among men in
either study (12,17). The other case-control study also showed no association between
colorectal cancer and trans fatty acid consumption (11). A cohort study, the Women's Health
Study, also examined trans fatty acid consumption but found no association (13). No previous
studies to which we could compare our results have examined the relationship between trans
fatty acid consumption and colon cancer in a large population of African Americans. Among
these studies, gram amounts of trans fatty acids consumption have varied. The levels seen in
our study population are among the highest, but still are not very different than levels of
consumption reported for other study populations. Therefore, differences in levels of
consumption are unlikely to explain the discrepancies in study results.
We have previously shown that high consumption of trans fatty acid is associated with higher
prevalence of colorectal adenomas (28). Other studies of adenomas have found no association
(29,30). Trans fatty acids may work to increase the risk of colorectal adenomas by altering the
concentration of fat and bile normally found in the colon (31), thereby irritating the colonic
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mucosa and resulting in increased oxidative stress (32) and inflammation (27,32). In addition,
some studies have shown that colonic bacteria metabolize bile acids to form compounds that
are carcinogenic and increase cellular proliferation (9,33-35). Trans fatty acids may also affect
insulin resistance (16,36,37), which could lead to increased cellular proliferation (38,39). It is
plausible that these mechanisms bring about changes in the mucosa that result in the formation
of adenomas but that trans fatty acid consumption does not affect the transition from adenoma
to cancer in the colon. Other studies have also found certain exposures to be associated with
colorectal adenomas but not with cancer. Despite the lack of association between trans fatty
acid consumption and colon cancer in our study, if trans fatty acids have even a moderate effect
on colorectal adenoma development, it can be expected that the current reductions in the
amount of trans fatty acids in the food supply, through voluntary removal from food products
and bans in the commercial food outlets of certain localities, will favorably affect the rates of
colon cancer.
The present study has several strengths, one of which is that we performed in-depth in-person
interviews. In addition, we had a large number of African Americans in the study population,
which permitted us to examine associations separately for Whites and African Americans, a
group that has not been examined with respect to trans fatty acid consumption and colon cancer.
Also, our study was geographically diverse, including individuals from urban, suburban, and
rural areas. There are limitations to the study as well. We did not have trans fatty acid values
for all of the foods options present in the Block FFQ. For example, fried chicken can be
classified as homemade or restaurant-made. These may have different amounts of trans fatty
acid but we assigned them the same value. This is unlikely to have greatly affected our results
as it was a potential problem for a small number of foods that contributed to only a minor part
of participants' reported diets. Also, the mean grams per day of trans fatty acid reported in our
study was comparable to that seen in similar studies, thereby supporting our estimates of
trans fatty acid values. There are always some errors inherent in dietary measurements using
food frequency questionnaires. First, participants' recall of their diet over the past year may
have been biased by their most recent consumption patterns. In addition, we have no
information on brands of food consumed, so we cannot differentiate between an individual
who consumed a specific food but chose a brand with low amounts of trans fatty acid from an
individual who chose the same food and a brand with high amounts of trans fatty acid.
Nonetheless, ranking individuals into quartiles based on their energy-adjusted trans fatty acid
consumption allowed us to compare risks according to relative amounts of consumption and
avoid bias due to minor misclassification of absolute levels of consumption. As with all case-
control analyses, our study was subject to selection and recall biases. However, selection bias
is likely to have been minimal because of high response rates among both cases and controls
and the randomized recruitment strategies employed. Recall bias is also unlikely to have
affected results, as no studies examining trans fatty acid consumption and colon/colorectal
cancer had been published prior to the completion of our study. In addition, for participants to
respond differentially, they would need to know the amount of trans fatty acids in each of the
foods present in the Block FFQ.
In conclusion, using data from a large case-control study, we found no association of trans
fatty acid consumption with colon cancer in either Whites or African Americans. Based on
these results, it is unlikely that trans fatty acid intake contributes to racial disparities in colon
cancer incidence.
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TABLE 1
Characteristics of the North Carolina Colon Cancer Study I (NCCCS I) population by case status and race, North
Carolina, 1996-2000
Participant Characteristics Whites (n=947) African-Americans (n=696)
Cases (n=341) Controls (n=606) Cases (n=282) Controls (n=414)
Age (%)
 <50 27 (7.92) 34 (5.61) 37 (13.12) 25 (6.04)
 50-59 66 (19.35) 108 (17.82) 73 (25.89) 81 (19.57)
 60-69 117 (34.31) 206 (33.99) 92 (32.62) 129 (31.16)
 >70 years 131 (38.42) 258 (42.57) 80 (28.37) 179 (43.24)
 Mean years (SD)‡ 65.06 (9.70) 66.16 (9.30) 62.04 (10.32) 65.94 (9.63)
Sex (%)
 Men 190 (55.72) 328 (54.13) 135 (47.87) 181 (43.72)
 Women 151 (44.28) 278 (45.87) 147 (52.13) 233 (56.28)
Education (%)
 ≤ High School 194 (57.06) 296 (48.84) 204 (72.34) 286 (69.08)
 Some college 69 (20.29) 148 (24.42) 50 (17.73) 73 (17.63)
 College graduate/advanced degree 77 (22.65) 162 (26.73) 28 (9.93) 55 (13.29)
Body Mass Index 1 year prior to enrollment (%)*
 Normal (18-24.9 kg/m2) 95 (28.53) 190 (31.99) 44 (15.94) 81 (20.72)
 Overweight (25-29.9 kg/m2) 139 (41.74) 250 (42.09) 113 (40.94) 145 (37.08)
 Obese (>=30 kg/m2) 99 (29.73) 154 (25.93) 119 (43.12) 165 (42.20)
 Mean kg/m2 (SD)‡ 28.37 (5.62) 27.57 (5.15) 30.07 (6.52) 29.73 (6.50)
Physical Activity (MET-minutes/day) (mean, %)*
 1st quartile 64 (18.93) 121 (20.17) 73 (27.24) 131 (32.11)
 2nd quartile 87 (25.74) 151 (25.17) 62 (23.13) 102 (25.00)
 3rd quartile 95 (28.11) 175 (29.17) 59 (22.01) 76 (18.63)
 4th quartile 92 (27.22) 153 (25.50) 74 (27.61) 99 (24.26)
 Mean MET-minutes/day (SD)‡ 2261.46 (565.66) 2199.71 (450.66) 2229.19 (566.56) 2154.99 (533.56)
Smoking status (%)
 Never 115 (33.92) 243 (40.10) 133 (47.50) 188 (45.41)
 Former 180 (53.10) 267 (44.06) 91 (32.50) 143 (34.54)
 Current 44 (12.98) 96 (15.84) 56 (20.00) 83 (20.05)
Family History (%)
 Yes 74 (21.83) 57 (9.48) 47 (16.67) 43 (10.41)
 No 265 (78.17) 544 (90.52) 235 (83.33) 370 (89.59)
NSAID use over the past 5 years (%)†
 Never 38 (11.18) 43 (7.10) 32 (11.35) 31 (7.49)
 Occasionally 128 (37.65) 173 (28.55) 123 (43.62) 133 (32.13)
 Regularly 174 (51.18) 390 (64.36) 127 (45.04) 250 (60.39)
Trans Fatty Acid Consumption
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Participant Characteristics Whites (n=947) African-Americans (n=696)
Cases (n=341) Controls (n=606) Cases (n=282) Controls (n=414)
 Mean grams/day (SD)‡ 5.85 (2.69) 5.17 (2.35) 6.07 (3.15) 5.20 (2.56)
Total Energy Intake
 Mean kcal/day (SD)‡ 1951.58 (689.12) 1784.01 (599.53) 1940.41 (832.11) 1697.62 (652.52)
Calcium Consumption§
 Mean milligrams/day (SD)‡ 868.97 (482.36) 980.24 (522.15) 676.62 (392.36) 672.15 (377.45)
Alcohol Consumption
 0 drinks/day 209 (61.29) 361 (59.57) 220 (78.01) 334 (80.68)
 >0 and ≤1 drink/day 81 (23.75) 182 (30.03) 38 (13.48) 67 (16.18)
 >1 drink/day 51 (14.96) 63 (10.40) 24 (8.41) 13 (3.14)
Fiber Consumption
 Mean grams/day (SD)‡ 14.18 (5.83) 13.95 (5.95) 13.89 (6.22) 14.03 (6.00)
Folate Consumption§
 Mean micrograms/day (SD)‡ 442.91 (240.16) 393.95 (222.73) 426.31 (252.64) 414.14 (230.36)
Red Meat Consumption
 Mean grams/day (SD)‡ 139.00 (94.96) 118.33 (80.06) 122.77 (85.56) 104.14 (77.85)
Red Meat Consumption
 Mean grams/day (SD)‡ 139.00 (94.96) 118.33 (80.06) 122.77 (85.56) 104.14 (77.85)
Fruit/Fruit juice Consumption
 Mean grams/day (SD)‡ 173.38 (147.34) 171.31 (140.04) 178.43 (169.17) 162.45 (133.40)
Vegetable Consumption
 Mean grams/day (SD)‡ 231.99 (107.13) 251.94 (123.00) 188.92 (117.43) 191.40 (105.37)
*
Data were missing for: Education (n=1), BMI (n=49), physical activity (n=29), smoking status (n=4) and family history (n=8), NSAID use (n=1)
†
Non-steroidal anti-inflammatory drug (NSAID) use is defined as Never for subjects who reported no use, Occasional for subjects who reported some




Combined dietary and supplemental intake
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